Our portfolio

InSteps

Providing in-silico modeling for stroke treatment, InSteps develops a platform to simulate various stroke scenarios. Their technology aids in the development of thrombectomy devices and optimizes clinical trials, giving more patients access to life-saving treatments. The company is committed to enhancing stroke care through advanced simulation technology.

Industry: Neuroscience, Simulation, Stroke

Want to get in contact about InSteps?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Advancing new therapeutics for Type 1 Diabetes and autoimmune diseases.
Reducing plastic waste and lowering CO2 emissions.
Upcycling phosphate waste into sustainable industrial products.
Improving elderly care with Night Nurse, an AI-powered patient monitoring system.
Advancing new therapeutics for Type 1 Diabetes and autoimmune diseases.
Reducing plastic waste and lowering CO2 emissions.
Upcycling phosphate waste into sustainable industrial products.
Improving elderly care with Night Nurse, an AI-powered patient monitoring system.